Zyus Life Sciences Quote - ZYUS

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.80

Bid

0.79

Offer

0.95

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

56.678M

Previous Close

0.80

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

70,847,000

Dividend Yield

PE Ratio

-1.33

Earnings Per Share (EPS)

-0.6

Revenue

351k

Net Profit

-42.59M

Sector

Pharmaceutical Preparations

Industry

Oil And Gas Field Expl Svcs

Website

www.zyus.com

Headquarters

Toronto, Ontario, Can

Founded

2023

Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.80. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Zyus Life Sciences currently has 70,847,000 shares in issue. The market capitalisation of Zyus Life Sciences is $56.68 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.33.

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Dec. 28, 2023 VANCOUVER, BC, Dec. 28, 2023 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2023-0415 DRYDEN GOLD CORP...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?

The current share price of Zyus Life Sciences is $ 0.80

How many Zyus Life Sciences shares are in issue?

Zyus Life Sciences has 70,847,000 shares in issue

What is the market cap of Zyus Life Sciences?

The market capitalisation of Zyus Life Sciences is CAD 56.68M

What is the 1 year trading range for Zyus Life Sciences share price?

Zyus Life Sciences has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Zyus Life Sciences?

The price to earnings ratio of Zyus Life Sciences is -1.33

What is the cash to sales ratio of Zyus Life Sciences?

The cash to sales ratio of Zyus Life Sciences is 160

What is the reporting currency for Zyus Life Sciences?

Zyus Life Sciences reports financial results in CAD

What is the latest annual turnover for Zyus Life Sciences?

The latest annual turnover of Zyus Life Sciences is CAD 351k

What is the latest annual profit for Zyus Life Sciences?

The latest annual profit of Zyus Life Sciences is CAD -42.59M

What is the registered address of Zyus Life Sciences?

The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3

What is the Zyus Life Sciences website address?

The website address for Zyus Life Sciences is www.zyus.com

Which industry sector does Zyus Life Sciences operate in?

Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0